This invention relates to compounds of the formula ##STR1## where R.sup.1 and R.sup.2 are both hydrogen or R.sup.1 and R.sup.2 form a bond; m=1 and n=3 and p=6, or m=3, 5 or 7 and n=1 and p=6, or m=4 and n=2 and p=6 or 8, and the E (trans) and Z (cis) isomers when R.sup.1 =R.sup.2 =H; and the basic addition salts thereof which are inhibitors of phospholipase A.sub.2 and are thus useful agents in the treatment of inflammatory diseases where arachidonic acid metabolic products are implicated, such as rheumatoid arthritis, inflammatory bowel diseases such as ulcerative colitis, atopic dermatitis conditions such as psoriasis and immediate hypersensitivity reactions such as allergic bronchial asthma and allergic rhinitis; and as gastric cytoprotective agents.
本发明涉及式子##STR1##的化合物,其中R.sup.1和R.sup.2都是氢,或者R.sup.1和R.sup.2形成键;m=1和n=3以及p=6,或者m=3、5或7,n=1和p=6,或者m=4,n=2和p=6或8,当R.sup.1=R.sup.2=H时,E(顺式)和Z(反式)异构体;以及它们的碱性加合盐,它们是
磷脂酶A.sub.2的
抑制剂,因此在治疗涉及
花生四烯酸代谢产物的炎症性疾病中,如类风湿性关节炎、炎症性肠病如溃疡性结肠炎、特应性皮炎等病症以及过敏性支气管哮喘和过敏性鼻炎等即时超敏反应中,它们是有用的药物;并作为胃黏膜保护剂。